Skip to Content


Active Substance: recombinant salmon calcitonin (rsct)
Common Name: recombinant salmon calcitonin
ATC Code: H05BA01
Marketing Authorisation Holder: Unigene UK Ltd.
Active Substance: recombinant salmon calcitonin (rsct)
Status: Withdrawn
Authorisation Date: 1999-01-11
Therapeutic Area: Hypercalcemia Osteitis Deformans Bone Resorption
Pharmacotherapeutic Group: Calcium homeostasis

Therapeutic Indication

Calcitonin is indicated for:
• Prevention of acute bone loss due to sudden immobilisation such as in patients with recent
osteoporotic fractures
• Paget's disease
• Hypercalcaemia of malignancy

The marketing authorisation for Forcaltonin has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.